[go: up one dir, main page]

BR9909324A - Composição acidificada para tratamento tópico de condições da pele e unha - Google Patents

Composição acidificada para tratamento tópico de condições da pele e unha

Info

Publication number
BR9909324A
BR9909324A BR9909324-3A BR9909324A BR9909324A BR 9909324 A BR9909324 A BR 9909324A BR 9909324 A BR9909324 A BR 9909324A BR 9909324 A BR9909324 A BR 9909324A
Authority
BR
Brazil
Prior art keywords
skin
topical treatment
relates
composition
nails
Prior art date
Application number
BR9909324-3A
Other languages
English (en)
Inventor
Ying Sun
Jue-Chen Liu
Elizabeth Kimbleton
Jonas C T Wang
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BR9909324A publication Critical patent/BR9909324A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO ACIDIFICADA PARA TRATAMENTO TóPICO DE CONDIçõES DA PELE E UNHA"<D>. A presente invenção refere-se a um método para o tratamento tópico de doenças da pele e unhas humanas, incluindo infecções fúngicas, infecções bacterianas e infecções psoriáticas. Além disso, a presente invenção se refere a um método de tratamento das condições gerais das unhas humanas, incluindo sua resistência, taxa de desenvolvimento e aparência. Mais particularmente, a invenção se refere a uma composição acidificada e métodos de uso da referida composição. Ainda, a invenção se refere a uma laca acidificada útil no tratamento de pele e unhas humanas.
BR9909324-3A 1998-03-31 1999-03-29 Composição acidificada para tratamento tópico de condições da pele e unha BR9909324A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8011698P 1998-03-31 1998-03-31
PCT/US1999/006740 WO1999049835A1 (en) 1998-03-31 1999-03-29 An acidified composition for topical treatment of nail and skin conditions

Publications (1)

Publication Number Publication Date
BR9909324A true BR9909324A (pt) 2000-12-05

Family

ID=22155365

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909324-3A BR9909324A (pt) 1998-03-31 1999-03-29 Composição acidificada para tratamento tópico de condições da pele e unha

Country Status (11)

Country Link
US (1) US6231875B1 (pt)
EP (1) EP1067897A1 (pt)
JP (1) JP2002509867A (pt)
KR (1) KR20010042324A (pt)
CN (1) CN1198563C (pt)
AR (1) AR015257A1 (pt)
AU (1) AU3211999A (pt)
BR (1) BR9909324A (pt)
CA (1) CA2326774A1 (pt)
TW (1) TWI225407B (pt)
WO (1) WO1999049835A1 (pt)

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
DE19639817A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
AUPO983897A0 (en) * 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US20030235607A1 (en) * 1998-02-13 2003-12-25 Buck Carol J. Compositions and methods for inhibiting fungal growth and transference
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
HRP20010576A2 (en) * 1999-02-03 2002-08-31 Biogal Gyogyszergyar Process for the preparation of pseudomonic acid a antibiotic by microbiological method
DE19921794A1 (de) * 1999-05-11 2000-11-23 Hexal Ag Neue pharmazeutische Zusammensetzung
CA2291346A1 (en) * 1999-11-26 2001-05-26 Bernard Charles Sherman Antifungal solutions
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
AU4318901A (en) * 2000-02-16 2001-08-27 Bentley Pharmaceuticals Inc Pharmaceutical composition
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
JP4814414B2 (ja) * 2000-05-26 2011-11-16 大正製薬株式会社 抗真菌液剤組成物
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
JP4899139B2 (ja) * 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP3838856B2 (ja) * 2000-09-11 2006-10-25 日本パーカライジング株式会社 アルミニウム含有金属材料用有機親水性処理剤及びその処理方法
US20040014848A1 (en) * 2000-09-11 2004-01-22 Kazuya Tanaka Organic Hydrophicizing agent for aluminiferous metals
DE10047486A1 (de) * 2000-09-26 2002-04-11 Bayer Ag Phenoxyphenyl Alkansulfonate
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
KR100435141B1 (ko) * 2000-12-28 2004-06-09 한미약품 주식회사 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6878365B2 (en) * 2001-03-10 2005-04-12 James Edward Brehove Topical application for treating toenail fungus
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
ES2228294T1 (es) * 2001-06-21 2005-04-16 Biogal Gyogyszergyar Rt. Proceso de fermentacion metabolico controlado para la produccion de acido pseudomonico.
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR100455216B1 (ko) * 2001-06-27 2004-11-09 한미약품 주식회사 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
WO2003047503A2 (en) * 2001-10-22 2003-06-12 University Of Mississippi Delivery of medicaments to the nail
US20040072810A1 (en) 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
AU2002356953A1 (en) * 2001-11-16 2004-06-03 Beatrice M. Klysz Anti-aging skin care composition and uses thereof
AU2002364898A1 (en) * 2001-11-30 2003-06-10 Almell, Ltd. Coating for nail care having antimicrobial properties
AU2002365431A1 (en) * 2001-12-28 2003-09-02 Teva Gyogyszergyar Reszvenytarsasag Processes for preparing crystalline and amorphous mupirocin calcium
US7198794B1 (en) 2002-02-22 2007-04-03 Lorri Riley Topical formulation for treating fingernails and toenails
CA2383296A1 (fr) * 2002-05-10 2003-11-10 Ginette Godbout Composition pour l'amelioration de la sante et de la structure des ongles, methode d'utilisation
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
US7491768B2 (en) * 2002-06-25 2009-02-17 Woong-Sig Moon Polymer resin formulation having anti-microbial or anti-coagulability and preparation method thereof
JP4081312B2 (ja) * 2002-06-28 2008-04-23 佐藤製薬株式会社 外用抗真菌剤
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
GB2392446A (en) * 2002-09-02 2004-03-03 Reckitt Benckiser Nv Resin comprising water-soluble polymer and water-soluble filler
AU2003270273B2 (en) * 2002-09-05 2009-03-19 Galderma S.A. Solution for ungual application
US7374772B2 (en) * 2002-11-07 2008-05-20 Bommarito Alexander A Topical antifungal treatment
WO2004046097A1 (en) * 2002-11-18 2004-06-03 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
AU2004206769B2 (en) 2003-01-24 2009-11-26 Stiefel Research Australia Pty Ltd Clindamycin phosphate foam
TW200501959A (en) * 2003-02-20 2005-01-16 Taisho Pharmaceutical Co Ltd Antifungal agents
US20040191194A1 (en) * 2003-03-28 2004-09-30 Carol Collins Nail composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
EP1637132B1 (en) * 2003-06-25 2010-10-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for athlete´s foot treatment
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2440172C (en) * 2003-09-05 2011-01-11 Bernard Charles Sherman Itraconazole solution
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2005104924A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 外用医薬組成物
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
ITMI20040312A1 (it) * 2004-02-24 2004-05-24 Euroderm R D C S P A Composizioni per il trattamento di patologie delle unghie e della pelle
ATE499416T1 (de) * 2004-05-12 2011-03-15 Akzo Nobel Coatings Int Bv Antimikrobielle säurekatalysierte beschichtungszusammensetzungen
DE602005019509D1 (de) * 2004-06-01 2010-04-08 Teva Gyogyszergyar Zartkoeruen Verfahren für die zubereitung der amorphen form eines medikamentes
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
CA2570245A1 (en) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections
US7842749B2 (en) * 2004-08-02 2010-11-30 Poly-Med, Inc. Tissue protecting spray-on copolymeric film composition
US20060068044A1 (en) * 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore
US20100092398A1 (en) * 2004-09-30 2010-04-15 Max Reynolds Antimicrobial compositions and applications therefore
US20060078599A1 (en) * 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
EP1874320A1 (en) * 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
US9173835B2 (en) 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
US7793666B2 (en) * 2005-07-28 2010-09-14 Innovation Biomedical Devices, Inc. Apparatus and method for treatment of infected nail
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
CN101378729B (zh) * 2005-12-14 2013-09-11 扎尔斯制药公司 治疗皮肤症状的制剂和方法
AU2006332425A1 (en) * 2006-01-02 2007-07-12 Tlt Medical Ltd. Pharmaceutical composition for the treatment of nail diseases
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd gel de suspensão espumante
WO2007113830A2 (en) * 2006-04-04 2007-10-11 Avner Shemer Kit for treating skin infection
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20080064669A1 (en) * 2006-08-29 2008-03-13 Rakefet Cohen Stable pharmacologically active compositions including vitamin D-containing and corticosteroid compounds with low pH compatibility
US8727855B2 (en) * 2006-11-13 2014-05-20 Igt Three-dimensional paylines for gaming machines
US20080153122A1 (en) * 2006-12-21 2008-06-26 Susan Beth Cantor Method and system for enhancing self-treatment of onychomycosis
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
WO2009084020A2 (en) * 2007-10-18 2009-07-09 Glenmark Pharmaceuticals Limited Topical composition comprising halobetasol and salicylic acid
WO2009062746A2 (de) * 2007-11-17 2009-05-22 Bayer Consumer Care Ag Topische arzneimittel zur antimykotischen therapie
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US20090298805A1 (en) * 2008-06-03 2009-12-03 Polson George A Topical pyrithione compositions and methods for treatment of nail fungus
US20090324713A1 (en) * 2008-06-30 2009-12-31 Ulman John T Spray-on, non-woven fabric system and multilayer wound coverings
US20090324664A1 (en) * 2008-06-30 2009-12-31 Ulman John T Spray-on, non-woven fabric system and multilayer topical covering
US20100021530A1 (en) * 2008-07-25 2010-01-28 Innovation Biomedical Devices, Inc. Enhanced trans-keratin drug delivery
WO2010014199A2 (en) * 2008-07-29 2010-02-04 The Board Of Regents Of The University Of Texas System Uses of morelloflavone
JP2012516320A (ja) * 2009-01-30 2012-07-19 イッスム リサーチ デベロプメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム リミテッド 爪および皮膚を処置するための組成物
WO2010086732A1 (en) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Stable compositions for nail and skin treatment
US20100275942A1 (en) * 2009-05-01 2010-11-04 Barile Maria A Cosmetic nail covering
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
EP2434892B1 (en) * 2009-05-29 2015-08-19 Palau Pharma, S.A. Azole antifungal compositions
CN102574791A (zh) 2009-08-05 2012-07-11 无限药品股份有限公司 环杷明类似物的酶促转氨基反应
AU2010283031A1 (en) * 2009-08-13 2012-01-19 Moberg Derma Ab Compositions and methods for treating fungal infection of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
WO2012037217A1 (en) 2010-09-14 2012-03-22 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
US20120082742A1 (en) * 2010-09-30 2012-04-05 Elorac, Ltd Method and compositions for treating cutaneous verrucae
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
FR2976806B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition topique filmogene et son utilisation pour le traitement des mycoses
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
KR101281470B1 (ko) * 2012-12-31 2013-07-03 전상문 피마자를 헥산으로 추출한 피마자유, 운데실렌산, 프로필알코올, 프로필렌글리콜 및 물을 함유하는 무좀 예방 또는 치료용 피부 외용제 조성물
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
JP6516759B2 (ja) 2013-10-03 2019-05-22 ダウ ファーマシューティカル サイエンシーズ，インコーポレイティド 安定化エフィナコナゾール組成物
KR102612453B1 (ko) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 항­감염 방법，조성물，및 장치
EP3091985B1 (en) 2014-01-10 2024-05-08 Manistee Therapeutics, Inc. Prostanglandins for topical use in the treatment of migraines.
US20160158393A1 (en) * 2014-02-21 2016-06-09 Avadim Technologies, Inc. Method for Improving Health Outcomes
CN106029156A (zh) 2014-02-21 2016-10-12 阿瓦蒂姆技术股份有限公司 维护尿道导管的方法
WO2015134500A1 (en) 2014-03-03 2015-09-11 Cook Medical Technologies Llc Mechanical dilator
JP2015212249A (ja) 2014-05-05 2015-11-26 アナコール ファーマシューティカルズ，インコーポレイテッド 化合物および爪光沢剤
DK3209319T3 (da) 2014-10-21 2021-10-04 Hexima Ltd En fremgangsmåde til behandling af svampeinfektioner
BR112017010557A2 (pt) 2014-11-19 2017-12-26 Avadim Tech Inc método para a prevenção e tratamento de acne
CN107613987A (zh) * 2015-03-31 2018-01-19 雷迪博士实验室有限公司 糠酸莫米松的局部喷雾组合物
US10369147B2 (en) 2015-06-04 2019-08-06 PellePharm, Inc. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
US20170231968A1 (en) * 2016-02-11 2017-08-17 PellePharm, Inc. Method for relief of and treatment of pruritus
JP2019509353A (ja) * 2016-03-24 2019-04-04 バイオクレンズ・ピーエイチ・リミテッド・ライアビリティ・カンパニーＢｉｏｃｌｅｎｚ Ｐｈ Ｌｌｃ 微生物バイオフィルムに関連する皮膚状態および疾患の処置
CN107115329A (zh) * 2017-04-28 2017-09-01 中国人民解放军第二军医大学第二附属医院 一种复方布替萘芬制剂及其应用
US12115139B2 (en) 2018-08-15 2024-10-15 Todd Alan Weinfield Treatment methods and processes for an infected nail
EP3982909A4 (en) 2019-06-12 2023-11-29 Avadim Health, Inc. COMPOSITIONS AND METHODS FOR ANTISEPTIC TREATMENT OF BIOFILMS ON MAMMALIAN TISSUE
KR102774439B1 (ko) 2022-11-11 2025-03-05 안재영 손톱 및 발톱용 화장품 조성물 및 이를 이용한 손톱 및 발톱 관리 방법

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR534810A (fr) 1921-04-19 1922-04-03 Dispositif de suspension à contrepoids et à poulies intérieures pour lampe électrique
DE1000567B (de) 1953-12-07 1957-01-10 Hans Fasching Erben K G Verfahren zur Erhaltung der pilzabtoetenden Wirkung von antimykotischen Substanzen bei Zugabe derselben zu nagelkeratin-aufweichenden Verbindungen (Thioglykolaten)
US4070317A (en) * 1968-05-29 1978-01-24 Deutsche Texaco Aktiengesellschaft Process for the production of film forming synthetic resins for hair fixatives
CH648481A5 (de) * 1981-06-26 1985-03-29 Joos Bernhard Nagelschutzpraeparat zur festigung und/oder haertung lebender finger- und/oder zehennaegel.
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
HU200914B (en) 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US4956467A (en) 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
JP2797401B2 (ja) * 1989-04-19 1998-09-17 日産化学工業株式会社 爪用抗真菌剤組成物
US5476852A (en) * 1989-05-03 1995-12-19 Janssen Pharmaceutica N.V. Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin
IL97012A0 (en) 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
IL94806A0 (en) 1990-06-20 1991-04-15 Ernest Bar On Pharmaceutical preparation containing thiol derivatives together with other active compounds
IT1249047B (it) 1991-02-21 1995-02-11 Zambon Spa Composizione farmaceutica per il trattamento della cataratta
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
EP0508324B1 (en) * 1991-04-10 1999-03-17 Ruey J. Dr. Yu Use of cosmetic compositions comprising 2-hydrocarboxylic acids and related compounds for alleviating signs of nail changes
FR2687913A1 (fr) * 1992-02-28 1993-09-03 Oreal Composition pour traitement topique contenant des vesicules lipidiques encapsulant au moins une eau minerale.
FR2689008A1 (fr) 1992-03-31 1993-10-01 Louis Benelli Compositions efficaces notamment contre la chute des cheveux et pour favoriser leur régénération ainsi que celle des ongles.
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
JPH06211651A (ja) * 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc 爪白癬治療用組成物
AU685082B2 (en) 1993-01-29 1998-01-15 Msd Consumer Care, Inc. Stable sulfide compositions, uses, and process for preparation thereof
IL105600A (en) 1993-05-04 1999-12-31 Allon Blank Pharmaceutical and cosmetic compositions with increased rate of transdermal penetration and antioxidation protection against degradation containing derivatives of thioglycolic and mercaptopropionic acids some such novel compounds and their use
US5461068A (en) * 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
PH31594A (en) * 1993-09-30 1998-11-03 Janssen Pharmaceutica Nv Oral formulations on an antifungal.
FR2714597B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition hydratante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
DE19604190A1 (de) 1996-02-06 1997-08-07 Hoechst Ag Nagelwachstumsfördernde Zubereitungen
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations

Also Published As

Publication number Publication date
HK1034189A1 (en) 2001-10-19
EP1067897A1 (en) 2001-01-17
AU3211999A (en) 1999-10-18
KR20010042324A (ko) 2001-05-25
JP2002509867A (ja) 2002-04-02
TWI225407B (en) 2004-12-21
CA2326774A1 (en) 1999-10-07
CN1295456A (zh) 2001-05-16
WO1999049835A1 (en) 1999-10-07
CN1198563C (zh) 2005-04-27
US6231875B1 (en) 2001-05-15
AR015257A1 (es) 2001-04-18

Similar Documents

Publication Publication Date Title
BR9909324A (pt) Composição acidificada para tratamento tópico de condições da pele e unha
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
FR2663850B1 (fr) Composition pharmaceutique ou cosmetique contenant en association un retinouide et un sterol.
BR0204596A (pt) Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada
CY1108633T1 (el) Κοσμητικη συνθεση βασεως σουκραλφατ και θειικων αλατων χαλκου και ψευδαργυρου
ATE220536T1 (de) Kosmetische und/oder dermatologische zusammensetzung enthaltend salicylsäure oder ihre derivate und ihre verwendung
FI973468L (fi) Hampaiden valkaisemiseen tai ihon ja limakalvojen sairauksien hoitoon käytettävien valmisteiden valmistusmenetelmä
DE69600239D1 (de) Verwendung eines Bradykinin-Antagonisten in einer kosmetischen, pharmazeutischen oder dermatologischen Zusammensetzung und die erhaltene Zusammensetzung
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
PT1173201E (pt) Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
AU2002366433A1 (en) Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
ES2162051T3 (es) Preparacion dermatologica para tratar queratosis actinicas.
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
BR9903750A (pt) Utilização de pelo menos um extrato de rosácea do gênero sanguisorba e processo cosmético de pigmentação da pele e/ou dos pêlos e/ou dos cabelos
BRPI0412424A (pt) composto, composição farmacêutica, método para tratar doenças dermatológicas ou cancerosas em um mamìfero, composição, e, método para tratar doenças relacionadas com a pele ou cancerosas
AU4626389A (en) Use of minoxidil for wound healing
PL369453A1 (en) Methods for improving the aesthetic appearance of skin
ATE240725T1 (de) Mittel zur behandlung lichtgeschädigter haut die einen rar-alpha antagonisten und ein multiselektives retinoid enthalten
AR004326A1 (es) Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista.
AU2859295A (en) New composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effect in human beings and animals
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
BR0204618A (pt) Métodos para tratamento de linhas finas e/ou de rugas, e para melhora a aparência estética da pele ou dos lábios, e, composição tópica
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1990 DE 25/02/2009.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 3/02 (2006.01), A61K 8/20 (2006.0